UFDI

Digestive and Inflammatory Diseases Research Unit

Detail Research lines Projects Publications Collaboration Theses

Date of inception 19 May 2016

Website: http://www.pharmacologyvalencia.com

At the beginning, our group was dedicated to the study and characterisation of gastrointestinal disorders related to acid production and motility, becoming an international reference group in this field due to the large number of high-level publications in the area of basic or experimental pharmacology. New applications for the study of drug effects, such as genetics or molecular biology, have led to a broadening of the topics to be studied. The most important characteristic of our group from a research point of view is the desire for our different lines of research to be focused on the study of physiological and pathological processes with a broad clinical impact. That is why our lines of research address diseases of particular relevance in today's society: Crohn's disease, NSAID gastroenteropathy, AIDS, diabetes and obesity. Since its foundation in 2007, our group has been part of the Centro de Investigación Biomédica en Red: Liver and Digestive Diseases (CIBERehd), whose function is to promote research of excellence at both clinical and basic levels. In addition, we have been recognised by the Valencian Government as a group of excellence within the PROMETEO 2010 call. Our group has published more than 200 articles and reviews in international journals including, among others, Gastroenterology, Hepatology, PNAS, Circulation, Immunity, Circulation Research, British Journal of Pharmacology and Trends in Pharmacological Sciences.